Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
anlotinib (1 trial)
bevacizumab (avastin) (1 trial)
docetaxel (taxotere) (1 trial)
ensartinib (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lung Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (4 total)